Literature DB >> 36222931

A molecular modeling on the potential application of beryllium oxide nanotube for delivery of hydroxyurea anticancer drug.

Mustafa M Kadhim1, Ali Jihad2, Safa K Hachim3,4, Sallal A H Abdullaha5, Taleeb Zedan Taban6, Ahmed Mahdi Rheima7.   

Abstract

Within this work, we scrutinized the use of BeO nanotube (BeONT) as a nanocarrier for the anticancer drug hydroxyurea (HU) through density functional theory (DFT) calculations. We utilized the functional ꞷB97XD and the basis set 6-31G**. Based on a detailed surface analysis, HU was adsorbed on the surface of the nanotube through 4 different orientations. Also, no vibrational spectra exhibited imaginary frequencies, showing the minimum energy of the relaxed structures. The maximum adsorption energy and the minimum adsorption energy are in strong physical adsorption. The BeONT exhibited p-type semiconducting characteristics in all orientations since it received electronic charge from HU. The results demonstrate the possibility of using the BeONT as a promising carrier for HU drugs.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adsorption energy; Density functional theory; Hydroxyurea; Promising carrier

Mesh:

Substances:

Year:  2022        PMID: 36222931     DOI: 10.1007/s00894-022-05343-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   2.172


  20 in total

1.  Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form.

Authors:  Gen Hasegawa; Takao Komasaka; Rui Bando; Yasuo Yoshihashi; Etsuo Yonemochi; Kotaro Fujii; Hidehiro Uekusa; Katsuhide Terada
Journal:  Int J Pharm       Date:  2008-11-05       Impact factor: 5.875

2.  Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction.

Authors:  Jin Yan; Yu Yao; Siqi Yan; Ruqing Gao; Wuyuan Lu; Wangxiao He
Journal:  Nano Lett       Date:  2020-06-30       Impact factor: 11.189

3.  Leg ulcers and hydroxyurea: forty-one cases.

Authors:  M E Sirieix; C Debure; N Baudot; L Dubertret; M E Roux; P Morel; C Frances; S Loubeyres; C Beylot; D Lambert; P Humbert; O Gauthier; M Dandurand; B Guillot; L Vaillant; G Lorette; J M Bonnetblanc; C Lok; J P Denoeux
Journal:  Arch Dermatol       Date:  1999-07

Review 4.  Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?

Authors:  Jianfeng Guo; Ludovic Bourre; Declan M Soden; Gerald C O'Sullivan; Caitriona O'Driscoll
Journal:  Biotechnol Adv       Date:  2011-03-22       Impact factor: 14.227

Review 5.  Engineered extracellular vesicles and their mimetics for cancer immunotherapy.

Authors:  Chunping Liu; Yichao Wang; Longmei Li; Dongyue He; Jiaxin Chi; Qin Li; Yixiao Wu; Yunxuan Zhao; Shihui Zhang; Lei Wang; Zhijin Fan; Yuhui Liao
Journal:  J Control Release       Date:  2022-07-28       Impact factor: 11.467

Review 6.  Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Authors:  Sophie Lanzkron; John J Strouse; Renee Wilson; Mary Catherine Beach; Carlton Haywood; HaeSong Park; Catherine Witkop; Eric B Bass; Jodi B Segal
Journal:  Ann Intern Med       Date:  2008-05-05       Impact factor: 25.391

Review 7.  Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review.

Authors:  A Meo; E Cassinerio; R Castelli; D Bignamini; L Perego; M D Cappellini
Journal:  Int J Lab Hematol       Date:  2008-10       Impact factor: 2.877

8.  Electrospun strong, bioactive, and bioabsorbable silk fibroin/poly (L-lactic-acid) nanoyarns for constructing advanced nanotextile tissue scaffolds.

Authors:  Jiao Liu; Tao Li; Hao Zhang; Wenwen Zhao; Lijun Qu; Shaojuan Chen; Shaohua Wu
Journal:  Mater Today Bio       Date:  2022-03-24

9.  Multimodal deep learning with feature level fusion for identification of choroidal neovascularization activity in age-related macular degeneration.

Authors:  Kai Jin; Yan Yan; Menglu Chen; Jun Wang; Xiangji Pan; Xindi Liu; Mushui Liu; Lixia Lou; Yao Wang; Juan Ye
Journal:  Acta Ophthalmol       Date:  2021-06-23       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.